The longer the delay between the appearance of the first symptoms of Hansen’s Disease and the start of treatment, the more likely it is for nerve damage to occur
2. ∗ To share difficulties
∗ Answer to queries
∗ Available evidence about surgery
Purpose
3. ∗ 25–30 per cent
∗ Reactions or nerve damage at one time or another
∗ The longer the delay between the appearance of the first
symptoms of Hansen’s Disease and the start of treatment,
the more likely it is for nerve damage to occur
Hansen’s Disease and nerve
damage
4. Risk of new nerve damage developing in new
cases of Hansen’s Disease
∗ Croft RP et al, A clinical prediction rule for nerve-function
impairment in leprosy patients. Lancet 2000;355: 1603-6.
PB MB
Nerve function at diagnosis 1% 16%
Impaired nerve function at diagnosis 16% 65%
5. ∗ Sudden increase in neural pathology
∗ Extension of MDT programmes
∗ Without adequate infrastructure to detect and treat early
neuritis
∗ Salafia A, Chauhan G. Nerve abscess in children and
adults leprosy patients: analysis of 145 cases and review
of the literature. Acta Leprol. 1996;10(1):45-50.
6. ∗ Primary impairment
∗ Muscle weakness and/or sensory loss
∗ Loss of sweating makes the skin more vulnerable to injury
∗ Secondary impairment
∗ Wounds, Ulcers, Osteomyelitis
∗ Loss of tissue (fingers/toes)
∗ Fixed contractures/deformities of hand or foot
∗ Corneal damage and its sequel
Nerve damage
7. ∗ Without obvious symptoms
∗ Can be presenting symptom
∗ New nerve damage during treatment
∗ Worsening in nerve damage on treatment
Manifestations
8. ∗ Late nerve damage (more than a year after completing
MDT)
∗ Nerve damage more than three years after completing MDT
(true relapse or reaction)
∗ Part of reaction
Manifestations
9.
10. ∗ Cranial and peripheral nerves
∗ Neuritis
∗ Thickened, tender or painful nerves
∗ Abscess
∗ Fibrosis
Nerve lesions
11. ∗ Screening for loss of protective sensation
∗ Nerve conduction studies
∗ Functional status of the muscles
∗ Electromyography
∗ MRI and MRN
∗ USG/Color Doppler
∗ Nerve biopsy/Skin biopsy
Investigations
12. ∗ Maas M, Slim EJ, Akkerman EM, Faber WR. MRI in clinically
asymptomatic neuropathic leprosy feet: a baseline study.
Int J Lepr Other Mycobact Dis. 2001 ;69(3):219-24.
∗ Department of Radiology, Suite G1-231, Academic Medical
Center, Meibergdreef 9, 1105 AZ Amsterdam Zuidoost, The
Netherlands.
MRI
13. ∗ Mainly in trauma
∗ MRN can add clinically useful diagnostic
information in many situations in which physical
examinations, electrodiagnostic tests, and existing
image techniques are inconclusive.
∗ Filler AG, Kliot M, Howe FA, Hayes CE, Saunders DE,
Goodkin R, Bell BA, Winn HR, Griffiths JR, Tsuruda JS.
Application of magnetic resonance neurography in the
evaluation of patients with peripheral nerve pathology. J
Neurosurg. 1996 ;85(2):299-309.
Magnetic resonance neurography (MRN)
14. ∗ US and MR imaging are able to detect nerves abnormalities
in leprosy. Active reversal reactions are indicated by
endoneural color flow signals as well as by an increased T2
signal and Gd enhancement. These signs would suggest
rapid progression of nerve damage and a poor prognosis
unless antireactional treatment is started.
Martinoli C, Derchi LE, Bertolotto M, Gandolfo N, Bianchi S, Fiallo P,
Nunzi E. US and MR imaging of peripheral nerves in leprosy. Skeletal
Radiol. 2000 ;29(3):142-50.
15. ∗ Thickened nerve and abscess
∗ Hari S, Subramanian S, Sharma R. Magnetic resonance imaging
of ulnar nerve abscess in leprosy: a case report. Lepr Rev. 2006
;77(4):381-5.
MRN
16. ∗ Skin lesions may not reflect the extent of nerve
involvement
∗ Clinical features may not reflect the extent of nerve
involvement
∗ Role of investigations to be defined
Difficulties
17. ∗ To stop permanent nerve damage
∗ Reverse the nerve damage
∗ Preventing mutilating damage
∗ Management of co-morbid conditions
∗ Rehabilitation
Management: Aim
18. ∗ Anti-inflammatory drugs and chemotherapy
∗ Early detection of leprosy and treatment with MDT remains
the best way to prevent disability
∗ Operative intervention
∗ Both
Management: Options
22. ∗ Number
∗ Extent
∗ Slowly progressive, rapid or fulminant
∗ Reversible or irreversible
∗ Extent of disability
∗ Status of immunity
Surgery: Assessment
23. ∗ Neurolysis
∗ External
∗ Extraneural
∗ Funicular
∗ Transposition
∗ Pandya SS. Surgery on the peripheral nerves in leprosy.
Neurosurg Rev. 1983;6(3):153-4.
Surgery: options
24. ∗ Treatment of nerve abscess
∗ Pandya SS. Surgery on the peripheral nerves in leprosy.
Neurosurg Rev. 1983;6(3):153-4.
∗ Agrawal A, Dalal M, Makkannavar JH, Shetty JP. Ulnar
nerve abscess and relapse in a patient with
indeterminate leprosy 1 year after completion of
multidrug therapy. Pediatr Neurosurg. 2005 ;41(3):162-4.
Surgery: options
25.
26. ∗ Excision of the granulomatous lesions
∗ Bridging with nerve autografts
∗ Sunderland S. The internal anatomy of nerve trunks in
relation to the neural lesions of leprosy. Observations
on pathology, symptomatology and treatment. Brain
1973 ; 96 :865-88.
Surgery: options
27. ∗ Major nerve trunks
∗ Need of long cable graft
∗ Limited donor material
∗ Sensory donor nerve-indispensable
∗ Diseased donor nerve
∗ Pereira JH, Cowley SA, Gschmeissner SE, Bowden REM,
Turk JL. Denatured muscle grafts for nerve repair an
experimental model of nerve damage in leprosy. J Bone
Joint Surg [Br J] 1990; 72-B:874-80.
Unsuccessful
28. ∗Free gracilis-muscle transfer
∗ Richard BM. Location of the extracranial extent of leprous
facial nerve pathology may allow leprous facial palsy to be
reanimated by free muscle transfer. Br J Plast Surg. 2003 ;
56(1):14-9.
Substitutes for nerves
29. ∗Autogenous muscle graft
∗ Pereira JH, Cowley SA, Gschmeissner SE, Bowden REM,
Turk JL. Denatured muscle grafts for nerve repair an
experimental model of nerve damage in leprosy. J Bone
Joint Surg [Br J] 1990; 72-B:874-80.
∗ Keynes RJ, Hopkins WC, Huang L-H. Regeneration of
mouse peripheral nerves in degenerating skeletal
muscle. Brain 1984; 29ı :275-8 1.
31. ∗ Role of surgery is still not well defined
∗ Malaviya GN. Shall we continue with nerve trunk
decompression in leprosy? Indian J Lepr. 2004;76(4):331-
42.
Challenges
32. ∗ Choice of a nerve
∗ Can we use infected nerve
∗ Healing of nerves
∗ Autologus graft
∗ Will it act as a source of bacilli
Challenges
33. ∗ Determining nerve damage
∗ Anticipating nerve damage
∗ Response to medical treatment
∗ Safety of medical treatment
∗ Wait for recovery
∗ When to intervene
Challenge
34. ∗ Mainly seen by neurologists and specialists
∗ Few experts
∗ Very few specialists in surgery
∗ Even fewer expert
∗ Reconstructive surgeons
∗ Hand surgeons
∗ Orthopedic surgery
Challenges
35. ∗ Patient is always on risk of nerve damage
∗ Best
∗ Surgery or medicine
∗ Surgery on nerves or reconstructive
∗ Nerve repair or graft or replacement
∗ Less consensus
∗ More controversies
Conclusion
Aim of my presentation will be to find out the answer to some queries and clarification of about available evidence
Probably 25–30 per cent of all people with leprosy experience reactions or nerve damage at one time or another
The longer the delay between the appearance of the first symptoms of leprosy and the start of treatment, the more likely it is for nerve damage to occur
Can be attributed, in part, to the extension of MDT programmes without adequate infrastructure to detect and treat early neuritis
Has a wide spectrum to damage
New nerve damage may occur without obvious symptoms
Nerve lesions can be the presenting symptom
New nerve damage during treatment
Worsening in nerve damage on treatment
Can involve both cranial and peripheral nerves
Is there any way to investigate neural fibrosis like MRI and MRN
If yes will it be able to predict the type of intervention
Whether skin lesions reflect the extent of nerve involvement?
No
Clinical features reflect the extent of nerve involvement?
No
Before clinical presentation a significant amount of damage has happened
Than how to assess
Reverse the nerve damage to the extent of full recovery
Management of co-morbid conditions (AIDS, diabetes, eye involvement, ulcers etc.)
Rehabilitation- functional and occupational
Preventing foot complications
Identifying those at risk
Emotional stress
Physical disability
Productivity and financial losses
Management of ulcers (particularly foot)
Early detection of leprosy and treatment with MDT remains the best way to prevent disability
Specialist and Multidisciplinary approach to deal and detect nerve injury in leprosy
Whether these are the problems
Whether is it a part of reaction
Whether this damage is happening in spite of treatment
Nerve swelling during management including MDT and steroids
Reaction
Is it possible to determine the extent of nerve damage?
Whether experts are available or not, medications, operative and intervention facilities, investigations
How much of the length of nerve is involved
Excision of the granulomatous lesions and bridging with nerve autografts
Major nerve trunks are involved
Needing long cable graft repairs with multiple cutaneous nerves
Limited donor material means that large lesions cannot be repaired
The loss even of one sensory nerve is detrimental to a patient already suffering from some anaesthesia
Finally the donor nerve may itself be diseased
Every nerve is indispensable particulary when these are compromised
When choosing a nerve is it normal or affected
Whether infected nerve can be used for graft
Healing of that nerve?
Whether infected graft will act as a source of bacilli as it may be difficult to eradicate the infection
Is it possible to determine and anticipate nerve damage
Who will respond to medical treatment
Medical treatment will not aggravate the nerve damage
Whether to wait for recovery in nerve function
Why these questions because there is very effective medical treatment is available
When to intervene and when to do the reconstruction
This issue is further complicated by the following facts
Mainly seen by neurologist and specialists in the fields
Lack of awareness and experts
Very few specialists in surgery
Even fewer surgeons with knowledge in reconstructive, hand, and orthopedic surgery
Need to define present consensus and controversies
Need to develop well defined non-controversial and management guidelines
It is important to realize that patient is always on risk of nerve damage even he is on treatment including steroids
One must search carefully for nerve damage in a leprosy patient